Back to FDA Applications sponsored by ALPHARMA PHARMS

FDA Drug Application 022321 by ALPHARMA PHARMS

Application Number022321
Application Type New Drug Application
Sponsor ApplicantALPHARMA PHARMS
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New combination
Therapeutic Potential Priority
Orphan Code 

Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP08/13/2009N33131000REMS 7/11/2012
AP08/13/2009N23201000 8/18/2009
AP08/13/2009N23204000 8/19/2009
AP08/13/2009N23273000 9/2/2009
AP08/13/2009N25609000 5/25/2010
AP08/13/2009N44374000FDA has determined that this product has abuse-deterrent properties 11/4/2015
AP07/9/2012SLR33116007 7/11/2012
AP07/9/2012SLR33154007 7/12/2012
AP04/15/2013SLR35743010 4/18/2013
AP06/3/2013SLR36197012 6/3/2013
AP06/3/2013SLR36203012 6/4/2013
AP011/1/2013SCM37693013 11/5/2013
AP010/17/2014SE840824016 10/17/2014
AP010/17/2014SE840825016 10/17/2014
AP010/17/2014SE840826016 10/17/2014
AP04/16/2014SLR39060017 4/16/2014
AP04/16/2014SLR39075017 4/17/2014
AP08/19/2014S40276018 8/20/2014
AP06/26/2015S43251019 7/6/2015
AP04/20/2016S45722021 4/22/2016
AP09/30/2016S47271023 10/4/2016

Back to FDA Applications sponsored by ALPHARMA PHARMS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer

Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.